VAS
PRME icon

Vestmark Advisory Solutions’s Prime Medicine PRME Stock Holding History

Vestmark Advisory Solutions’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-78,599
Closed -$156K – 805
2025
Q1 		$156K Sell
78,599
-32,866
-29% -$83.8K ﹤0.01% 616
2024
Q4 		$460K Buy
111,465
+21,429
+24% +$75.2K 0.02% 422
2024
Q3 		$348K Sell
90,036
-13,476
-13% -$62.4K 0.01% 422
2024
Q2 		$532K Sell
103,512
-43,972
-30% -$267K 0.02% 393
2024
Q1 		$1.03M Buy
147,484
+3,196
+2% +$24.2K 0.04% 311
2023
Q4 		$1.28M Buy
+144,288
New +$1.11M 0.06% 264

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vestmark Advisory Solutions's PRME Position: Q2 2025 in Review

Vestmark Advisory Solutions sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 78,599 shares — an estimated $156K sold.

Vestmark Advisory Solutions first reported a position in PRME in Q4 2023 and held it in 6 quarters. The position peaked at $1.28M in Q4 2023. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.

  • Vestmark Advisory Solutions reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 78,599 Prime Medicine shares in Q2 2025, an estimated $156K.
  • Vestmark Advisory Solutions first reported a position in Prime Medicine in Q4 2023 and held it in 6 quarters.
  • Vestmark Advisory Solutions's Prime Medicine position peaked at $1.28M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.